CYTK vs ELVN Stock Comparison

ELVN currently leads CYTK in this stock comparison, with AIQ scores of 71 vs 40. The clearest difference is quality.

Market data as of Nov 15, 2026 market close· AIQ score gap 31 points
CYTK
Healthcare
vs
ELVN
Healthcare
CYTK
Cytokinetics, Incorporated
Price
$56.13
Day move
-0.05%
AIQ Score
40/100
Best edge
Balanced
Sector
Healthcare
ELVN
Enliven Therapeutics, Inc.
Leads
Price
$48.80
Day move
+1.01%
AIQ Score
71/100
Best edge
Quality
Sector
Healthcare

What is the main difference between CYTK and ELVN?

ELVN leads the current stock comparison as Enliven Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Cytokinetics, Incorporated vs Enliven Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

ELVN leads

ELVN leads by 31 AIQ points, primarily on Quality and Momentum, and the lead has widened from 17 points over 30 sessions. Wall Street currently favors CYTK on target upside.

Competitive: 2 of 5 evidence groups support ELVN, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Strengthening
CYTK

Cytokinetics, Incorporated

AIQ Score
40/100
AIQ Edge Score
2/10
ELVN

Enliven Therapeutics, Inc.

Leads
AIQ Score
71/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors ELVN over CYTK, 71 versus 40 as of Nov 15, 2026. ELVN's advantage is driven primarily by stronger quality and momentum. ELVN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors CYTK. 2 of 5 covered evidence groups favor ELVN today, and the comparison is rated Competitive on stability: only 2 of 5 covered evidence groups agree. ELVN lead: Strengthening — the AIQ differential moved from 17 to 31 points over 30 sessions.

Compare Cytokinetics, Incorporated and Enliven Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

CYTK
+31.1%
ELVN
+105.5%

Price return comparison

Growth of $10,000, price only

CYTK $13,111 · ELVN $20,547

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare CYTK and ELVN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CYTK advantage
0
ELVN advantage
  • Quality46 vs 84
    ELVN +38
  • Momentum28 vs 66
    ELVN +38
  • Risk Resilience56 vs 56
    Even

2 of 5 evidence groups favor ELVN. ELVN’s edge is concentrated in quality and momentum.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

CYTK-1 AIQ

Largest factor move: Momentum -3

New signals

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (3.0%)
ELVN+2 AIQ

Largest factor move: Momentum +5

No signal started or stopped since the prior session; its 6 active signals are unchanged.

ELVN's lead widened by 3 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — CYTK and ELVN both carry a full feed there.

The central trade-off

ELVN (Enliven Therapeutics, Inc.): the stronger current systematic profile, led by quality and momentum.

CYTK (Cytokinetics, Incorporated): the counter-case, on analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ELVN

ELVN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CYTK

CYTK on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ELVN

ELVN on the Momentum factor, by 38 points.

Lower downside

CYTK

CYTK carries the lower 1-month annualized volatility.

Analyst upside

CYTK

CYTK on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ELVN, analyst targets favor CYTK. That disagreement is the most useful thing on this page.

MeasureCYTKELVNNote
Implied upside to target+77%+50.6%CYTK has more room
Target dispersion+32.2%+10.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2214Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor ELVN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreELVN40 vs 71
FundamentalsEvenEPS growth 8.7% vs 26.5%; TTM ROE 59.2% vs -3.2%
ValuationNot coveredNot covered
TechnicalsELVNPrice vs 50-day -12.5% vs 5.1%; vs 200-day -19.6% vs 11.3%
Risk ResilienceEvenRisk Resilience 56 vs 56
Analyst expectationsCYTKTarget upside 77% vs 50.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CYTK and ELVN and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 31 points. (supports the conclusion holding)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ELVN.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ELVN lead: Strengthening — the AIQ differential moved from 17 to 31 points over 30 sessions.

May 27CYTK leads above the line · ELVN leads belowNov 13
Today
ELVN +31
40 vs 71
7 sessions ago
ELVN +28
41 vs 69
30 sessions ago
ELVN +17
45 vs 62
90 sessions ago
ELVN +31
52 vs 83

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CYTK

0 bullish / 3 bearish / 1 neutral

Only CYTK

  • Death Cross Active — bearish, trend, long horizon (8.84%)
  • 52-Week Low Proximity — bearish, risk_regime, long horizon (3.0%)
  • Downtrend Structure Active — bearish, trend, long horizon
ELVNConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

Only ELVN

  • Golden Cross Active — bullish, trend, long horizon (5.93%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.61x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

ELVN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CYTKNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.05%, AIQ -1 points).

ELVNConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +1.01%, AIQ +2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CYTK closes the Quality gap — currently 38 points behind, the largest single contributor to ELVN's edge.
  2. 2CYTK's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ELVN's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricCYTKELVN
Revenue growth (YoY)66.1%0%
EPS growth (YoY)8.7%26.5%
Gross margin91%0%
Operating margin-6.3%0%
Return on equity (TTM)59.2%-3.2%
Debt to equity-3.960

Performance

ELVN leads 5 of 6 windows
MetricCYTKELVN
1 week (5 sessions)4.5%-1.3%
1 month (20 sessions)-9.4%30.8%
3 months (63 sessions)-26%-18%
6 months (126 sessions)-26%18%
Year to date-11.7%216.9%
1 year (252 sessions)-14.9%140.4%

Technicals

ELVN has the stronger structure
MetricCYTKELVN
RSI (14)38.257.3
ADX (14)25.727.8
Price vs 50-day-12.5%5.1%
Price vs 200-day-19.6%11.3%
Volatility (1M, annualized)57%60.3%

Risk

Split
MetricCYTKELVN
Beta1.011.1
Sharpe ratio-0.231.43
Sortino ratio-0.323.07
Max drawdown-38.5%-39%
Current drawdown-35.7%-20.2%
Annualized volatility43.7%78.2%
Value at risk (95%)-4%-5.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CYTK or ELVN?

On the Algovestiq AIQ Score, ELVN is the stronger of the two as of Nov 15, 2026, scoring 71 against CYTK's 40. The edge comes from quality and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CYTK or ELVN the better buy right now?

ELVN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 2 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor ELVN over CYTK?

The composite weights Quality, Value, Momentum and Risk Resilience. ELVN leads Quality by 38 points; ELVN leads Momentum by 38 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CYTK or ELVN?

Analyst price targets imply +77% upside for CYTK and +50.6% for ELVN, so the Street currently favors CYTK. That points the opposite way to the AIQ Score, which favors ELVN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CYTK or ELVN?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CYTK or ELVN?

CYTK on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CYTK or ELVN?

ELVN on the Momentum factor, by 38 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CYTK or ELVN?

CYTK is the more resilient of the two, so the other name carries the higher downside risk. CYTK carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CYTK more profitable than ELVN?

CYTK leads on the comparable margin measures — gross margin 91% vs 0%; operating margin -6.3% vs 0%; ttm roe 59.2% vs -3.2%.

Is ELVN's lead over CYTK getting stronger or weaker?

ELVN lead: Strengthening — the AIQ differential moved from 17 to 31 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the CYTK vs ELVN verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CYTK closes the Quality gap — currently 38 points behind, the largest single contributor to ELVN's edge; CYTK's Death Cross Active resolves — a bearish trend rule currently active against it; ELVN's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about CYTK and ELVN?

CYTK: 0 bullish / 3 bearish / 1 neutral. ELVN: 4 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CYTK is Death Cross Active (bearish, long horizon). On ELVN it is Golden Cross Active (bullish, long horizon).

Compare CYTK and ELVN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.